Profit and Loss Results Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
1,004.00
969.00
816.00
794.00
647.00
602.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,004.00
969.00
816.00
794.00
647.00
602.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
1.00
1.00
1.00
1.00
0.00
0.00
General and Administration Expenses
298.00
299.00
274.00
295.00
310.00
320.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
723.00
760.00
705.00
742.00
769.00
843.00
Operating Profit (PBDIT) excl Other Income
281.00
209.00
110.00
51.00
-122.00
-240.00
Other Income
15.00
1.00
15.00
-144.00
-143.00
-69.00
Operating Profit (PBDIT)
314.00
226.00
128.00
-107.00
-265.00
-310.00
Interest
1.00
1.00
1.00
1.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
18.00
15.00
2.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
300.00
209.00
124.00
-280.00
-250.00
-310.00
Provision for Tax
-28.00
-39.00
-62.00
9.00
8.00
8.00
Profit After Tax
329.00
249.00
186.00
-289.00
-258.00
-318.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
35.33
26.74
20.05
-31.11
-27.78
-34.23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 3.66% vs 18.71% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 34.36% vs 88.61% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 5.79% vs 11.50% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 32.11% vs 33.40% in Mar 2025
Compare Profit and Loss Results of Immuno-Biological Laboratories Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
1,004.00
32,908.00
-31,904.00
-96.95%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,004.00
32,908.00
-31,904.00
-96.95%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
1.00
37.00
-36.00
-97.30%
General and Administration Expenses
298.00
4,969.00
-4,671.00
-94.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
723.00
32,144.00
-31,421.00
-97.75%
Operating Profit (PBDIT) excl Other Income
281.00
763.00
-482.00
-63.17%
Other Income
15.00
156.00
-141.00
-90.38%
Operating Profit (PBDIT)
314.00
1,220.00
-906.00
-74.26%
Interest
1.00
37.00
-36.00
-97.30%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
18.00
299.00
-281.00
-93.98%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
300.00
825.00
-525.00
-63.64%
Provision for Tax
-28.00
251.00
-279.00
-111.16%
Profit After Tax
329.00
586.00
-257.00
-43.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
35.3268
101.2211
-65.89
-65.10%
Profit And Loss - Net Sales
Net Sales 1,004.99 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 3.66% vs 18.71% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 281.28 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 34.36% vs 88.61% in Mar 2025
Profit And Loss - Interest
Interest 1.33 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 5.79% vs 11.50% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 329.01 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 32.11% vs 33.40% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
